A detailed history of Childress Capital Advisors, LLC transactions in Danaher Corp stock. As of the latest transaction made, Childress Capital Advisors, LLC holds 2,186 shares of DHR stock, worth $515,546. This represents 0.17% of its overall portfolio holdings.

Number of Shares
2,186
Previous 2,031 7.63%
Holding current value
$515,546
Previous $507,000 19.72%
% of portfolio
0.17%
Previous 0.15%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$239.25 - $280.76 $37,083 - $43,517
155 Added 7.63%
2,186 $607,000
Q2 2024

Aug 05, 2024

SELL
$235.51 - $267.98 $13,659 - $15,542
-58 Reduced 2.78%
2,031 $507,000
Q1 2024

Apr 24, 2024

BUY
$224.58 - $256.19 $7,411 - $8,454
33 Added 1.61%
2,089 $521,000
Q4 2023

Feb 16, 2024

BUY
$185.1 - $233.13 $54,974 - $69,239
297 Added 16.88%
2,056 $475,000
Q3 2023

Nov 06, 2023

BUY
$233.08 - $265.59 $409,987 - $467,172
1,759 New
1,759 $436,000
Q4 2022

Feb 03, 2023

SELL
$241.42 - $282.29 $159,820 - $186,875
-662 Reduced 28.91%
1,628 $432,000
Q3 2022

Nov 03, 2022

BUY
$247.06 - $1507.4 $57,564 - $351,224
233 Added 11.33%
2,290 $596,000
Q2 2022

Aug 15, 2022

BUY
$237.11 - $299.66 $151,987 - $192,082
641 Added 45.27%
2,057 $521,000
Q1 2022

May 10, 2022

SELL
$257.27 - $315.76 $40,391 - $49,574
-157 Reduced 9.98%
1,416 $415,000
Q4 2021

Jan 26, 2022

SELL
$292.08 - $329.01 $114,203 - $128,642
-391 Reduced 19.91%
1,573 $518,000
Q3 2021

Nov 15, 2021

BUY
$272.21 - $332.43 $139,915 - $170,869
514 Added 35.45%
1,964 $597,000
Q2 2021

Jul 28, 2021

SELL
$225.08 - $271.69 $27,009 - $32,602
-120 Reduced 7.64%
1,450 $389,000
Q1 2021

May 21, 2021

BUY
$212.38 - $245.9 $110,649 - $128,113
521 Added 49.67%
1,570 $353,000
Q4 2020

Mar 09, 2021

BUY
$212.5 - $245.46 $222,912 - $257,487
1,049 New
1,049 $233,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $172B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Childress Capital Advisors, LLC Portfolio

Follow Childress Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Childress Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Childress Capital Advisors, LLC with notifications on news.